Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has announced a purchase agreement with Defspace, an India-based global platform for defence, space and aerospace, for the company's Safe Entry's Fit for Duty screening.
The company said Defspace will lease four Safe Entry Stations which will be used by their clients in the defence and aerospace sector to screen their workforce for signs of impairment - an issue that hinders productivity and threatens health and safety across all operations. The total value of the purchase order is approximately $500,000 for the entire term, it added.
"Impairment is a huge concern for many industries and sectors worldwide. Safe Entry's Fit for Duty screening ensures workforces are fit for duty by screening individuals' key vital signs,” Predictmedix chief operating officer Dr Rahul Kushwah said in a statement.
READ: Predictmedix announces independent clinical validation for its AI-powered screening
“When an individual is impaired by alcohol or cannabis, Safe Entry will let you know. The multi-spectral cameras and AI algorithms scan for a multitude of physiological factors and behaviors - indicating intoxication, impairment, sickness, and extreme fatigue," he added. "Safe Entry is a strong line of defence against encumbered employees, and we are excited to announce our first contract in the defence sector.”.
The company noted that DefSpace operates an exclusive global platform for defence, space and aerospace. The platform offers secured and authorised connections between buyers and sellers, investment opportunities, job opportunities and many services that add significant value to companies that are already working in the defence, space and aerospace sector or for those just entering the field.
"The technology developed by Predictmedix addresses a key unmet need in several sectors which not only includes healthcare and workplace but also the defence and aerospace industry,” DefSpace founders Anushka Shah and Jiwanshi Shah said. “We are excited and confident of the positive impact the technology will be making in the defence sector.”
Guru Bakshish Singh Sehgal, head of Indian operations at Predictmedix, concluded: "We are excited to be moving ahead with commercialization in the defence space with DefSpace and are seeing tremendous interest across multiple verticals.”
Predictmedix is an emerging provider of rapid health screening and remote patient care solutions globally. The company's Safe Entry Stations - powered by a proprietary artificial intelligence (AI) - use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including infectious diseases such as COVID-19, impairment by drugs or alcohol, fatigue or various mental illnesses.
Contact the author at stephen.gunnion@proactiveinvestors.com